Details of the Drug
General Information of Drug (ID: DMD4LGN)
| Drug Name |
AZ-TAK1
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | TAK1 inhibitor (mantle cell lymphoma), AstraZeneca; TGF-beta-activated kinase 1 inhibitor (mantle cell lymphoma), AstraZeneca | ||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||

